The use of human hepatocyte cultures to study the induction of cytochrome P-450

Drug Metabolism and Disposition

Volumn 27, Issue 8, 1999, Pages 887-894

  Kostrubsky, Vsevolod E ^a   Ramachandran, Vinod ^b   Venkataramanan, Raman ^b   Dorko, Kenneth ^a   Esplen, James E ^a   Zhang, Shimin ^b   Sinclair, Jacqueline F ^c,d   Wrighton, Steven A ^e   Strom, Stephen C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Universigy of Pittsburgh   (United States)

^c VA MEDICAL CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PACLITAXEL; RIFAMYCIN; TESTOSTERONE; TROLEANDOMYCIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; DRUG HYDROXYLATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0032794135     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Benedetti MS and Dostert P (1994) Induction and autoinduction properties of rifampicin derivatives: A review of animal and human studies. Environ Health Perspect 102:101-105.
2. Chang TK, Gonzales FJ and Waxman DJ (1994) Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch Biochem Biophys 311:437-442.
3. Chang TK, Yu L, Maurel P and Waxman DJ (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: Response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res 57:1946-1954.
4. Crespi CL and Penman BW (1997) Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interaction. Adv Pharmacol 43:171-188.
5. Cresteil T, Monsarrat B, Alvinerie P, Treluyer JM, Vieira I and Wright M (1994) Taxol metabolism by human liver microsomes: Identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 54:386-392.
6. Daujat M, Pichard L, Fabre I, Pineau T, Fabre G, Bonifils C and Maurel P (1991) Induction protocols for cytochrome P450 IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods Enzymol 206:345-353.
7. Ged C, Rouillon JM, Pichard L, Combalbert J, Bresson N, Bories P, Michel H, Beaune P and Maurel P (1989) The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Phamacol 28:373-387.
8. Harris JW, Rahman A, Kim BR, Guengerich PF and Collins JM (1994) Metabolism of Taxol by human hepatic microsomes and liver slices: Participation of cytochrome P450 3A and an unknown P450 enzyme. Cancer Res 54:4026-4035.
9. Kostrubsky VE, Lewis LD, Strom SC, Wood SG, Schuetz EG, Schuetz JD, Sinclair PR, Wrighton SA and Sinclair JF (1998) Induction of CYP3A by Taxol in primary cultures of human hepatocytes. Arch Biochem Biophys 355:131-136.
10. Kostrubsky VE, Lewis LD, Wood SG, Sinclair PR, Wrighton SA and Sinclair JF (1997) Effect of Taxol on cytochrome P450 3A and acetaminophen toxicity in cultured rat hepatocytes: Comparison to dexamethasone. Toxicol Appl Pharmacol 142:79-86.
11. Kostrubsky VE, Strom SC, Wood SG, Wrighton SA, Sinclair PR and Sinclair JF (1995) Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Arch Biochem Biophys 322:516-520.
12. Kurowski V and Wagner T (1993) Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde and 2-and 3-dechloroethyliifosfamide in patients on fractionated intravenous ifosfamide therapy. Cancer Chemother Pharmacol 33:36-42.
13. Li AP (1997) Primary hepatocyte cultures as an in vitro experimental model for the evaluation of pharmacokinetic drug-drug interactions. Adv Pharmacol 43:103-130.
14. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
15. Maurel P (1996) The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man. Adv Drug Delivery Rev 22:105-132.
16. Monsarrat B, Chatelut E, Royer I, Alvinerie P, Dubois J, Dezeuse A, Roche H, Cros S, Wright M and Canal P (1998) Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metab Dispos 26:229-233.
17. Newton DJ, Wang RW and Lu AYH (1995) Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154-158.
18. Ohnhaus EE and Park BK (1979) Measurements of urinary 6-β-hydroxycortisol excretion as in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbilone and rifampicin. Eur J Clin Pharmacol 15:139-145.
19. Pichard L, Fabre I, Fabre G, Domergue J, Aubert BS, Mourad G and Maurel P (1990) Cyclosporin A drug interactions. Drug Metab Dispos 18:595-606.
20. Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, Li D and Guzelian PS (1993) Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262.
21. Sidhu JS and Omiecinski CJ (1995) Modulation of xenobiotic-inducible cytochrome P450 gene expression by dexamethasone in primary rat hepatocytes. Pharmacogenetics 5:24-36.
22. Silva JM, Morin PE, Day SH, Kennedy BP, Payette P, Rushmore T, Yergey JA and Nicoll-Griffith DA (1998) Refinement of an in vitro cell model for cytochrome P450 induction. Drug Metab Dispos 26:490-496.
23. Sonnichsen DS, Liu Q, Schuetz EG, Schuetz JD, Pappo A and Relling M (1995) Variability in human cytochrome P450 paclitaxel metabolism. J Pharmacol Exp Ther 275:566-575.
24. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD and Schuetz EG (1996) Use of human hepatocytes to study P450 gene induction. Methods Enzymol 272:388-401.
25. Uziely B, Jeffers S and Muggia F (1994) Low doses of dexamethasone protect against Paclitaxel (Taxol)-related hypersensitivity reactions following cycle 1. Ann Oncol 5:474.
26. Venkatesan K (1992) Pharmacokinetic drug interactions with rifampicin. Clin Pharmacokinet 22:47-65.
27. Waxman DJ, Attsano C, Guengerich PF and Lapenson D (1988) Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 263:424-436.
28. Waxman DJ, Ko A and Walsh C (1983) Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem 258:11937-11947.
29. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV and Gonzalez FJ (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450 enzymes. Arch Biochem Biophys 290:160-166.
30. Wrighton SA, Brian WR, Sari A-A, Iwasaki M, Guengerich PF, Raucy JL, Molowa DT and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.